Are CD4+CD25-Foxp3+cells in untreated new-onset lupus patients regulatory T cells?
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Introduction: Our previous study has reported that, in patients with untreated new-onset lupus (UNOL), there was an abnormal increase in the number of CD4+CD25-Foxp3+ T cells that correlated with disease activity and significantly decreased after treatment. However, little is known about the nature of this cell entity. The aim of this study was to explore the nature of abnormally increased CD4+CD25-Foxp3+ T cells in UNOL patients. Methods: The expressions of surface (CD4, CD25, CD127, chemokine receptor 4 [CCR4], glucocorticoid-induced tumor necrosis factor receptor [GITR], and cytotoxic T lymphocyte-associated antigen 4 [CTLA-4]) and intracellular (Foxp3) molecules as well as cytokine synthesis of peripheral blood mononuclear cells from 22 UNOL patients were analyzed by flow cytometry. The proliferative and suppressive capacities of different T-cell subgroups from UNOL patients were also assessed. Results: In UNOL patients, the percentages of CD127 low/- in CD25 high, CD25 low, and CD25- subpopulations of CD4+Foxp3+ T cells were 93.79% ± 3.48%, 93.66% ± 2.31%, and 91.98% ± 2.14%, respectively (P > 0.05), whereas the expressions of Foxp3 showed significant differences in CD25 high (91.38% ± 2.57%), CD25 low (71.89% ± 3.31%), and CD25- (9.02% ± 2.21%) subpopulations of CD4+CD127 low/- T cells (P < 0.01). The expressions of surface CCR4, GITR, and CTLA-4 on CD4+CD25-Foxp3+ T cells were significantly less than CD4+CD25+Foxp3+ T cells (P < 0.05). Moreover, unlike CD4+CD25+Foxp3+ T cells, CD4+CD25-Foxp3+ T cells also synthesized interferon-gamma, interleukin (IL)-4, IL-2, and IL-17 (P < 0.05), though less than CD4+CD25+Foxp3- T cells. The suppressive capacity was most prominent in CD4+CD25 high CD127 low/-, followed by CD4+CD25 low CD127 low/-. CD4+CD25-CD127- T cells showed the least suppressive capacity, which was similar to the effector T cells. Conclusions: CD4+CD25-Foxp3+ T cells in UNOL patients are different from regulatory T cells, both phenotypically and functionally. CD127 is not an appropriate surface marker for intracellular Foxp3 in CD4+CD25- T cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak, T. W., & Sakaguchi, S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.303 · Cited by 2,233 · cited 1×
“CTLA-4 is also predominantly expressed on CD4+CD25+ Tregs from thymus and peripheral blood and participates in the maintenance of immunologic self-tolerance [ 6 ].”
CD4+CD25+ Immunoregulatory T Cells
McHugh, R. S., Whitters, M. J., Piccirillo, C. A., Young, D. A., Shevach, E. M., Collins, M., & Byrne, M. C. (2002) · Immunity · doi:10.1016/s1074-7613(02)00280-7 · Cited by 1,395
Allan, S. E., Crome, S. Q., Crellin, N. K., Passerini, L., Steiner, T. S., Bacchetta, R., Roncarolo, M. G., & Levings, M. K. (2007) · International Immunology · doi:10.1093/intimm/dxm014 · Cited by 872 · cited 1×
“Foxp3 is also expressed on some activated CD4+ T cells [12].”
Cited by
von Spee-Mayer, C., Siegert, E., Abdirama, D., Rose, A., Klaus, A., Alexander, T., Enghard, P., Sawitzki, B., Hiepe, F., Radbruch, A., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207776 · Cited by 349
Bao, W., Bussel, J. B., Heck, S., He, W., Karpoff, M., Boulad, N., & Yazdanbakhsh, K. (2010) · Blood · doi:10.1182/blood-2010-04-281717 · Cited by 345
Self-citationHuman FoxP3+ regulatory T cells in systemic autoimmune diseases
Miyara, M., Gorochov, G., Ehrenstein, M., Musset, L., Sakaguchi, S., & Amoura, Z. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.05.004 · Cited by 342
Regulatory T cells in systemic lupus erythematosus
Ohl, K., & Tenbrock, K. (2015) · European Journal of Immunology · doi:10.1002/eji.201344280 · Cited by 262
Treg cells in autoimmunity: from identification to Treg-based therapies
Göschl, L., Scheinecker, C., & Bonelli, M. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00741-8 · Cited by 214
Generation and Immune Regulation of CD4+CD25-Foxp3) T Cells in Chronic Obstructive Pulmonary Disease
Wu, J.-H., Zhou, M., Jin, Y., Meng, Z.-J., Xiong, X.-Z., Sun, S.-W., Miao, S.-Y., Han, H.-L., & Tao, X.-N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00220 · Cited by 26
Harpaz, I., Bhattacharya, U., Elyahu, Y., Strominger, I., & Monsonego, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00283 · Cited by 22
Ju, B., Zhu, L., Wang, J., Zheng, J., Hao, Z., Luo, J., Zhang, J., Hu, N., An, Q., Feng, X., et al. (2022) · BMC Immunology · doi:10.1186/s12865-022-00517-0 · Cited by 14
Metadata
- Authors
- Yang, H.-X., Zhang, W., Zhao, L.-D., Li, Y., Zhang, F.-C., Tang, F.-L., He, W., & Zhang, X.
- Venue
- Arthritis Research & Therapy
- Published
- 2009-10-12
- Volume
- 11
- Issue
- 5
- Pages
- R153-R153
- ISSN
- 1478-6354 (ISSN-L)
- OpenAlex
- W2053302471
- Cited by
- 79
- References
- 3
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.